 | • レポートコード：MMG23DC16497 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英語、PDF、76ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品 |
| Single User（1名様閲覧用） | ￥487,500 (USD3,250) | ▷ お問い合わせ |
| Multi User（20名様閲覧用） | ￥633,750 (USD4,225) | ▷ お問い合わせ |
| Enterprise User（閲覧人数制限なし） | ￥731,250 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界のノロウイルス用ワクチン市場規模と予測を収録しています。・世界のノロウイルス用ワクチン市場：売上、2018年-2023年、2024年-2029年 ・世界のノロウイルス用ワクチン市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界のノロウイルス用ワクチン市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「二価」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 ノロウイルス用ワクチンのグローバル主要企業は、Hillevax、 Vaxart、 Moderna、 UMN Pharma、 Daiichi Sankyo、 Kanghua Biology、 Beijing Institute of Biological Products、 Zhifei Bio、 China Biotechnology Co., Ltd.、 North China Pharmaceuticalなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、ノロウイルス用ワクチンのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界のノロウイルス用ワクチン市場：タイプ別、2018年-2023年、2024年-2029年 世界のノロウイルス用ワクチン市場：タイプ別市場シェア、2022年 ・二価、四価、六価 世界のノロウイルス用ワクチン市場：用途別、2018年-2023年、2024年-2029年 世界のノロウイルス用ワクチン市場：用途別市場シェア、2022年 ・病院、クリニック、その他 世界のノロウイルス用ワクチン市場：地域・国別、2018年-2023年、2024年-2029年 世界のノロウイルス用ワクチン市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業におけるノロウイルス用ワクチンのグローバル売上、2018年-2023年 ・主要企業におけるノロウイルス用ワクチンのグローバル売上シェア、2022年 ・主要企業におけるノロウイルス用ワクチンのグローバル販売量、2018年-2023年 ・主要企業におけるノロウイルス用ワクチンのグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Hillevax、 Vaxart、 Moderna、 UMN Pharma、 Daiichi Sankyo、 Kanghua Biology、 Beijing Institute of Biological Products、 Zhifei Bio、 China Biotechnology Co., Ltd.、 North China Pharmaceutical ************************************************************* ・調査・分析レポートの概要 ノロウイルス用ワクチン市場の定義 市場セグメント 世界のノロウイルス用ワクチン市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界のノロウイルス用ワクチン市場規模 世界のノロウイルス用ワクチン市場規模：2022年 VS 2029年 世界のノロウイルス用ワクチン市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでのノロウイルス用ワクチンの売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業のノロウイルス用ワクチン製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：二価、四価、六価 ノロウイルス用ワクチンのタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：病院、クリニック、その他 ノロウイルス用ワクチンの用途別グローバル売上・予測 ・地域別市場分析 地域別ノロウイルス用ワクチン市場規模 2022年と2029年 地域別ノロウイルス用ワクチン売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Hillevax、 Vaxart、 Moderna、 UMN Pharma、 Daiichi Sankyo、 Kanghua Biology、 Beijing Institute of Biological Products、 Zhifei Bio、 China Biotechnology Co., Ltd.、 North China Pharmaceutical ... |
This research report provides a comprehensive analysis of the Norovirus Vaccine market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Norovirus Vaccine market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Norovirus Vaccine, challenges faced by the industry, and potential opportunities for market players.
The global Norovirus Vaccine market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Norovirus Vaccine market presents opportunities for various stakeholders, including Hospital, Clinic. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Norovirus Vaccine market. Additionally, the growing consumer demand present avenues for market expansion.
The global Norovirus Vaccine market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Norovirus, a human caliciviridae virus, is mainly transmitted through the fecal-oral route and is highly contagious. It has no obvious pathogenicity in healthy people, but can cause serious illness and complications in immunocompromised patients, the elderly and children. It can last for a long time, and the main symptoms of infection are diarrhea and vomiting. Norovirus vaccines can effectively prevent viral infections, but the current existing vaccines fail to meet clinical needs, resulting in a large demand gap. As people’s health awareness increases, there will be a huge demand for norovirus vaccines in the future.
Key Features:
The research report on the Norovirus Vaccine market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Norovirus Vaccine market.
Market Overview: The report provides a comprehensive overview of the Norovirus Vaccine market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Bivalent, Quadrivalent), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Norovirus Vaccine market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Norovirus Vaccine market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Norovirus Vaccine market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Norovirus Vaccine market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Norovirus Vaccine market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Norovirus Vaccine market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Norovirus Vaccine, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Norovirus Vaccine market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Norovirus Vaccine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Bivalent
Quadrivalent
Hexavalent
Market segment by Application
Hospital
Clinic
Others
Global Norovirus Vaccine Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Hillevax
Vaxart
Moderna
UMN Pharma
Daiichi Sankyo
Kanghua Biology
Beijing Institute of Biological Products
Zhifei Bio
China Biotechnology Co., Ltd.
North China Pharmaceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Norovirus Vaccine, market overview.
Chapter 2: Global Norovirus Vaccine market size in revenue and volume.
Chapter 3: Detailed analysis of Norovirus Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Norovirus Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Norovirus Vaccine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Norovirus Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Norovirus Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Norovirus Vaccine Overall Market Size
2.1 Global Norovirus Vaccine Market Size: 2022 VS 2029
2.2 Global Norovirus Vaccine Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Norovirus Vaccine Sales: 2018-2029
3 Company Landscape
3.1 Top Norovirus Vaccine Players in Global Market
3.2 Top Global Norovirus Vaccine Companies Ranked by Revenue
3.3 Global Norovirus Vaccine Revenue by Companies
3.4 Global Norovirus Vaccine Sales by Companies
3.5 Global Norovirus Vaccine Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Norovirus Vaccine Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Norovirus Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Norovirus Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Norovirus Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Norovirus Vaccine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Norovirus Vaccine Market Size Markets, 2022 & 2029
4.1.2 Bivalent
4.1.3 Quadrivalent
4.1.4 Hexavalent
4.2 By Type – Global Norovirus Vaccine Revenue & Forecasts
4.2.1 By Type – Global Norovirus Vaccine Revenue, 2018-2023
4.2.2 By Type – Global Norovirus Vaccine Revenue, 2024-2029
4.2.3 By Type – Global Norovirus Vaccine Revenue Market Share, 2018-2029
4.3 By Type – Global Norovirus Vaccine Sales & Forecasts
4.3.1 By Type – Global Norovirus Vaccine Sales, 2018-2023
4.3.2 By Type – Global Norovirus Vaccine Sales, 2024-2029
4.3.3 By Type – Global Norovirus Vaccine Sales Market Share, 2018-2029
4.4 By Type – Global Norovirus Vaccine Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Norovirus Vaccine Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application – Global Norovirus Vaccine Revenue & Forecasts
5.2.1 By Application – Global Norovirus Vaccine Revenue, 2018-2023
5.2.2 By Application – Global Norovirus Vaccine Revenue, 2024-2029
5.2.3 By Application – Global Norovirus Vaccine Revenue Market Share, 2018-2029
5.3 By Application – Global Norovirus Vaccine Sales & Forecasts
5.3.1 By Application – Global Norovirus Vaccine Sales, 2018-2023
5.3.2 By Application – Global Norovirus Vaccine Sales, 2024-2029
5.3.3 By Application – Global Norovirus Vaccine Sales Market Share, 2018-2029
5.4 By Application – Global Norovirus Vaccine Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Norovirus Vaccine Market Size, 2022 & 2029
6.2 By Region – Global Norovirus Vaccine Revenue & Forecasts
6.2.1 By Region – Global Norovirus Vaccine Revenue, 2018-2023
6.2.2 By Region – Global Norovirus Vaccine Revenue, 2024-2029
6.2.3 By Region – Global Norovirus Vaccine Revenue Market Share, 2018-2029
6.3 By Region – Global Norovirus Vaccine Sales & Forecasts
6.3.1 By Region – Global Norovirus Vaccine Sales, 2018-2023
6.3.2 By Region – Global Norovirus Vaccine Sales, 2024-2029
6.3.3 By Region – Global Norovirus Vaccine Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Norovirus Vaccine Revenue, 2018-2029
6.4.2 By Country – North America Norovirus Vaccine Sales, 2018-2029
6.4.3 US Norovirus Vaccine Market Size, 2018-2029
6.4.4 Canada Norovirus Vaccine Market Size, 2018-2029
6.4.5 Mexico Norovirus Vaccine Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Norovirus Vaccine Revenue, 2018-2029
6.5.2 By Country – Europe Norovirus Vaccine Sales, 2018-2029
6.5.3 Germany Norovirus Vaccine Market Size, 2018-2029
6.5.4 France Norovirus Vaccine Market Size, 2018-2029
6.5.5 U.K. Norovirus Vaccine Market Size, 2018-2029
6.5.6 Italy Norovirus Vaccine Market Size, 2018-2029
6.5.7 Russia Norovirus Vaccine Market Size, 2018-2029
6.5.8 Nordic Countries Norovirus Vaccine Market Size, 2018-2029
6.5.9 Benelux Norovirus Vaccine Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Norovirus Vaccine Revenue, 2018-2029
6.6.2 By Region – Asia Norovirus Vaccine Sales, 2018-2029
6.6.3 China Norovirus Vaccine Market Size, 2018-2029
6.6.4 Japan Norovirus Vaccine Market Size, 2018-2029
6.6.5 South Korea Norovirus Vaccine Market Size, 2018-2029
6.6.6 Southeast Asia Norovirus Vaccine Market Size, 2018-2029
6.6.7 India Norovirus Vaccine Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Norovirus Vaccine Revenue, 2018-2029
6.7.2 By Country – South America Norovirus Vaccine Sales, 2018-2029
6.7.3 Brazil Norovirus Vaccine Market Size, 2018-2029
6.7.4 Argentina Norovirus Vaccine Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Norovirus Vaccine Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Norovirus Vaccine Sales, 2018-2029
6.8.3 Turkey Norovirus Vaccine Market Size, 2018-2029
6.8.4 Israel Norovirus Vaccine Market Size, 2018-2029
6.8.5 Saudi Arabia Norovirus Vaccine Market Size, 2018-2029
6.8.6 UAE Norovirus Vaccine Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Hillevax
7.1.1 Hillevax Company Summary
7.1.2 Hillevax Business Overview
7.1.3 Hillevax Norovirus Vaccine Major Product Offerings
7.1.4 Hillevax Norovirus Vaccine Sales and Revenue in Global (2018-2023)
7.1.5 Hillevax Key News & Latest Developments
7.2 Vaxart
7.2.1 Vaxart Company Summary
7.2.2 Vaxart Business Overview
7.2.3 Vaxart Norovirus Vaccine Major Product Offerings
7.2.4 Vaxart Norovirus Vaccine Sales and Revenue in Global (2018-2023)
7.2.5 Vaxart Key News & Latest Developments
7.3 Moderna
7.3.1 Moderna Company Summary
7.3.2 Moderna Business Overview
7.3.3 Moderna Norovirus Vaccine Major Product Offerings
7.3.4 Moderna Norovirus Vaccine Sales and Revenue in Global (2018-2023)
7.3.5 Moderna Key News & Latest Developments
7.4 UMN Pharma
7.4.1 UMN Pharma Company Summary
7.4.2 UMN Pharma Business Overview
7.4.3 UMN Pharma Norovirus Vaccine Major Product Offerings
7.4.4 UMN Pharma Norovirus Vaccine Sales and Revenue in Global (2018-2023)
7.4.5 UMN Pharma Key News & Latest Developments
7.5 Daiichi Sankyo
7.5.1 Daiichi Sankyo Company Summary
7.5.2 Daiichi Sankyo Business Overview
7.5.3 Daiichi Sankyo Norovirus Vaccine Major Product Offerings
7.5.4 Daiichi Sankyo Norovirus Vaccine Sales and Revenue in Global (2018-2023)
7.5.5 Daiichi Sankyo Key News & Latest Developments
7.6 Kanghua Biology
7.6.1 Kanghua Biology Company Summary
7.6.2 Kanghua Biology Business Overview
7.6.3 Kanghua Biology Norovirus Vaccine Major Product Offerings
7.6.4 Kanghua Biology Norovirus Vaccine Sales and Revenue in Global (2018-2023)
7.6.5 Kanghua Biology Key News & Latest Developments
7.7 Beijing Institute of Biological Products
7.7.1 Beijing Institute of Biological Products Company Summary
7.7.2 Beijing Institute of Biological Products Business Overview
7.7.3 Beijing Institute of Biological Products Norovirus Vaccine Major Product Offerings
7.7.4 Beijing Institute of Biological Products Norovirus Vaccine Sales and Revenue in Global (2018-2023)
7.7.5 Beijing Institute of Biological Products Key News & Latest Developments
7.8 Zhifei Bio
7.8.1 Zhifei Bio Company Summary
7.8.2 Zhifei Bio Business Overview
7.8.3 Zhifei Bio Norovirus Vaccine Major Product Offerings
7.8.4 Zhifei Bio Norovirus Vaccine Sales and Revenue in Global (2018-2023)
7.8.5 Zhifei Bio Key News & Latest Developments
7.9 China Biotechnology Co., Ltd.
7.9.1 China Biotechnology Co., Ltd. Company Summary
7.9.2 China Biotechnology Co., Ltd. Business Overview
7.9.3 China Biotechnology Co., Ltd. Norovirus Vaccine Major Product Offerings
7.9.4 China Biotechnology Co., Ltd. Norovirus Vaccine Sales and Revenue in Global (2018-2023)
7.9.5 China Biotechnology Co., Ltd. Key News & Latest Developments
7.10 North China Pharmaceutical
7.10.1 North China Pharmaceutical Company Summary
7.10.2 North China Pharmaceutical Business Overview
7.10.3 North China Pharmaceutical Norovirus Vaccine Major Product Offerings
7.10.4 North China Pharmaceutical Norovirus Vaccine Sales and Revenue in Global (2018-2023)
7.10.5 North China Pharmaceutical Key News & Latest Developments
8 Global Norovirus Vaccine Production Capacity, Analysis
8.1 Global Norovirus Vaccine Production Capacity, 2018-2029
8.2 Norovirus Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Norovirus Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Norovirus Vaccine Supply Chain Analysis
10.1 Norovirus Vaccine Industry Value Chain
10.2 Norovirus Vaccine Upstream Market
10.3 Norovirus Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Norovirus Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
Table 1. Key Players of Norovirus Vaccine in Global Market
Table 2. Top Norovirus Vaccine Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Norovirus Vaccine Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Norovirus Vaccine Revenue Share by Companies, 2018-2023
Table 5. Global Norovirus Vaccine Sales by Companies, (K Units), 2018-2023
Table 6. Global Norovirus Vaccine Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Norovirus Vaccine Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Norovirus Vaccine Product Type
Table 9. List of Global Tier 1 Norovirus Vaccine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Norovirus Vaccine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Norovirus Vaccine Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Norovirus Vaccine Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Norovirus Vaccine Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Norovirus Vaccine Sales (K Units), 2018-2023
Table 15. By Type - Global Norovirus Vaccine Sales (K Units), 2024-2029
Table 16. By Application – Global Norovirus Vaccine Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Norovirus Vaccine Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Norovirus Vaccine Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Norovirus Vaccine Sales (K Units), 2018-2023
Table 20. By Application - Global Norovirus Vaccine Sales (K Units), 2024-2029
Table 21. By Region – Global Norovirus Vaccine Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Norovirus Vaccine Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Norovirus Vaccine Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Norovirus Vaccine Sales (K Units), 2018-2023
Table 25. By Region - Global Norovirus Vaccine Sales (K Units), 2024-2029
Table 26. By Country - North America Norovirus Vaccine Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Norovirus Vaccine Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Norovirus Vaccine Sales, (K Units), 2018-2023
Table 29. By Country - North America Norovirus Vaccine Sales, (K Units), 2024-2029
Table 30. By Country - Europe Norovirus Vaccine Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Norovirus Vaccine Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Norovirus Vaccine Sales, (K Units), 2018-2023
Table 33. By Country - Europe Norovirus Vaccine Sales, (K Units), 2024-2029
Table 34. By Region - Asia Norovirus Vaccine Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Norovirus Vaccine Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Norovirus Vaccine Sales, (K Units), 2018-2023
Table 37. By Region - Asia Norovirus Vaccine Sales, (K Units), 2024-2029
Table 38. By Country - South America Norovirus Vaccine Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Norovirus Vaccine Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Norovirus Vaccine Sales, (K Units), 2018-2023
Table 41. By Country - South America Norovirus Vaccine Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Norovirus Vaccine Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Norovirus Vaccine Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Norovirus Vaccine Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Norovirus Vaccine Sales, (K Units), 2024-2029
Table 46. Hillevax Company Summary
Table 47. Hillevax Norovirus Vaccine Product Offerings
Table 48. Hillevax Norovirus Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Hillevax Key News & Latest Developments
Table 50. Vaxart Company Summary
Table 51. Vaxart Norovirus Vaccine Product Offerings
Table 52. Vaxart Norovirus Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Vaxart Key News & Latest Developments
Table 54. Moderna Company Summary
Table 55. Moderna Norovirus Vaccine Product Offerings
Table 56. Moderna Norovirus Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Moderna Key News & Latest Developments
Table 58. UMN Pharma Company Summary
Table 59. UMN Pharma Norovirus Vaccine Product Offerings
Table 60. UMN Pharma Norovirus Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. UMN Pharma Key News & Latest Developments
Table 62. Daiichi Sankyo Company Summary
Table 63. Daiichi Sankyo Norovirus Vaccine Product Offerings
Table 64. Daiichi Sankyo Norovirus Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Daiichi Sankyo Key News & Latest Developments
Table 66. Kanghua Biology Company Summary
Table 67. Kanghua Biology Norovirus Vaccine Product Offerings
Table 68. Kanghua Biology Norovirus Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Kanghua Biology Key News & Latest Developments
Table 70. Beijing Institute of Biological Products Company Summary
Table 71. Beijing Institute of Biological Products Norovirus Vaccine Product Offerings
Table 72. Beijing Institute of Biological Products Norovirus Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Beijing Institute of Biological Products Key News & Latest Developments
Table 74. Zhifei Bio Company Summary
Table 75. Zhifei Bio Norovirus Vaccine Product Offerings
Table 76. Zhifei Bio Norovirus Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Zhifei Bio Key News & Latest Developments
Table 78. China Biotechnology Co., Ltd. Company Summary
Table 79. China Biotechnology Co., Ltd. Norovirus Vaccine Product Offerings
Table 80. China Biotechnology Co., Ltd. Norovirus Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. China Biotechnology Co., Ltd. Key News & Latest Developments
Table 82. North China Pharmaceutical Company Summary
Table 83. North China Pharmaceutical Norovirus Vaccine Product Offerings
Table 84. North China Pharmaceutical Norovirus Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. North China Pharmaceutical Key News & Latest Developments
Table 86. Norovirus Vaccine Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 87. Global Norovirus Vaccine Capacity Market Share of Key Manufacturers, 2021-2023
Table 88. Global Norovirus Vaccine Production by Region, 2018-2023 (K Units)
Table 89. Global Norovirus Vaccine Production by Region, 2024-2029 (K Units)
Table 90. Norovirus Vaccine Market Opportunities & Trends in Global Market
Table 91. Norovirus Vaccine Market Drivers in Global Market
Table 92. Norovirus Vaccine Market Restraints in Global Market
Table 93. Norovirus Vaccine Raw Materials
Table 94. Norovirus Vaccine Raw Materials Suppliers in Global Market
Table 95. Typical Norovirus Vaccine Downstream
Table 96. Norovirus Vaccine Downstream Clients in Global Market
Table 97. Norovirus Vaccine Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Norovirus Vaccine Segment by Type in 2022
Figure 2. Norovirus Vaccine Segment by Application in 2022
Figure 3. Global Norovirus Vaccine Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Norovirus Vaccine Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Norovirus Vaccine Revenue, 2018-2029 (US$, Mn)
Figure 7. Norovirus Vaccine Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Norovirus Vaccine Revenue in 2022
Figure 9. By Type - Global Norovirus Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Norovirus Vaccine Revenue Market Share, 2018-2029
Figure 11. By Type - Global Norovirus Vaccine Sales Market Share, 2018-2029
Figure 12. By Type - Global Norovirus Vaccine Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Norovirus Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Norovirus Vaccine Revenue Market Share, 2018-2029
Figure 15. By Application - Global Norovirus Vaccine Sales Market Share, 2018-2029
Figure 16. By Application - Global Norovirus Vaccine Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Norovirus Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Norovirus Vaccine Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Norovirus Vaccine Revenue Market Share, 2018-2029
Figure 20. By Region - Global Norovirus Vaccine Sales Market Share, 2018-2029
Figure 21. By Country - North America Norovirus Vaccine Revenue Market Share, 2018-2029
Figure 22. By Country - North America Norovirus Vaccine Sales Market Share, 2018-2029
Figure 23. US Norovirus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Norovirus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Norovirus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Norovirus Vaccine Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Norovirus Vaccine Sales Market Share, 2018-2029
Figure 28. Germany Norovirus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 29. France Norovirus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Norovirus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Norovirus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Norovirus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Norovirus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Norovirus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Norovirus Vaccine Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Norovirus Vaccine Sales Market Share, 2018-2029
Figure 37. China Norovirus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Norovirus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Norovirus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Norovirus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 41. India Norovirus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Norovirus Vaccine Revenue Market Share, 2018-2029
Figure 43. By Country - South America Norovirus Vaccine Sales Market Share, 2018-2029
Figure 44. Brazil Norovirus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Norovirus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Norovirus Vaccine Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Norovirus Vaccine Sales Market Share, 2018-2029
Figure 48. Turkey Norovirus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Norovirus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Norovirus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Norovirus Vaccine Revenue, (US$, Mn), 2018-2029
Figure 52. Global Norovirus Vaccine Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Norovirus Vaccine by Region, 2022 VS 2029
Figure 54. Norovirus Vaccine Industry Value Chain
Figure 55. Marketing Channels